Thursday, September 10, 2009
Glaxo's Cervarix vaccine moves towards US approval; Merck's Gardasil wins backing for boys
WASHINGTON - Drugmaker Merck probably will face U.S. competition for its vaccine Gardasil after federal experts recommended that rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment